Paperpal Prime Logo

Immunotherapy : Impact Factor & More

eISSN: 1750-7448pISSN: 1750-743X

Key Metrics

CiteScore
5.7
Eigenfactor
0.005 - 0.01
H-Index
59
Impact Factor
< 5
SJR
Q2Oncology
SNIP
0.7
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Immunotherapy

Immunotherapy Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher FUTURE MEDICINE LTD
Language English
Frequency Semi-monthly
General Details
LanguageEnglish
FrequencySemi-monthly
Publication Start Year2009
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Immunotherapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Immunotherapy

Safety and tolerability of a new intravenous immunoglobulin 10% in patients with primary immunodeficiency.
  • 7 Aug 2026
  • Immunotherapy
Impact of sublingual immunotherapy with dust mite drops on ECP, TARC, VCAM-1 inflammatory status in patients with allergic rhinitis.
  • 4 Aug 2026
  • Immunotherapy
Lupus nephritis treatment: a comprehensive overview of recent meta-analyses and future directions.
  • 18 Jul 2026
  • Immunotherapy
Disrupting neuro-immune feedback loops: novel targets to amplify cancer immunotherapy.
  • 27 May 2026
  • Immunotherapy
Next-generation cancer immunotherapy: the promise of CAR T-Cell therapy.
  • 4 May 2026
  • Immunotherapy
Exploring global research trends in sublingual immunotherapy of allergic rhinitis: a comprehensive bibliometric analysis.
  • 1 May 2026
  • Immunotherapy
Safety and tolerability of a new intravenous immunoglobulin 10% in patients with primary immunodeficiency.
  • 7 Aug 2026
  • Immunotherapy
Impact of sublingual immunotherapy with dust mite drops on ECP, TARC, VCAM-1 inflammatory status in patients with allergic rhinitis.
  • 4 Aug 2026
  • Immunotherapy
Lupus nephritis treatment: a comprehensive overview of recent meta-analyses and future directions.
  • 18 Jul 2026
  • Immunotherapy
Disrupting neuro-immune feedback loops: novel targets to amplify cancer immunotherapy.
  • 27 May 2026
  • Immunotherapy
Next-generation cancer immunotherapy: the promise of CAR T-Cell therapy.
  • 4 May 2026
  • Immunotherapy
Exploring global research trends in sublingual immunotherapy of allergic rhinitis: a comprehensive bibliometric analysis.
  • 1 May 2026
  • Immunotherapy

FAQs on Immunotherapy